Advertisement
Screener

HUMAN GENOME SCIENCES INC Increase (Decrease) in Prepaid Expense and Other Assets

HUMAN GENOME SCIENCES INC Increase (Decrease) in Prepaid Expense and Other Assets

HUMAN GENOME SCIENCES INC reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.38 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2012-07-26

  • HUMAN GENOME SCIENCES INC increase (decrease) in prepaid expense and other assets for the quarter ending 2012-06-30 was $1.72M.
  • HUMAN GENOME SCIENCES INC increase (decrease) in prepaid expense and other assets for the quarter ending 2012-03-31 was -$344.00K, a 110.44% decline year-over-year.
  • HUMAN GENOME SCIENCES INC increase (decrease) in prepaid expense and other assets for the quarter ending 2011-12-31 was -$4.38M, a 1287.80% decline year-over-year.
  • HUMAN GENOME SCIENCES INC increase (decrease) in prepaid expense and other assets for the quarter ending 2011-09-30 was $8.09M.
  • HUMAN GENOME SCIENCES INC increase (decrease) in prepaid expense and other assets for fiscal 2011 was $4.01M.
  • HUMAN GENOME SCIENCES INC increase (decrease) in prepaid expense and other assets for fiscal 2010 was -$2.11M, a 228.66% decline from fiscal 2009.
  • HUMAN GENOME SCIENCES INC increase (decrease) in prepaid expense and other assets for fiscal 2009 was $1.64M.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month
2012-06-30$1.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26
$1.38M
10-Q · filed 2012-07-26
-$3.00M
derived: sum of 3 quarters · filed 2012-07-26
$5.08M
derived: sum of 4 quarters · filed 2012-07-26
2012-03-31-$344.00K
10-Q · filed 2012-04-26
-$4.73M
derived: sum of 2 quarters · filed 2012-04-26
$3.36M
derived: sum of 3 quarters · filed 2012-04-26
$371.00K
derived: sum of 4 quarters · filed 2012-07-26
2011-12-31-$4.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
$3.70M
derived: sum of 2 quarters · filed 2012-02-28
$715.00K
derived: sum of 3 quarters · filed 2012-07-26
$4.01M
10-K · filed 2012-02-28
2011-09-30$8.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28
$5.10M
derived: sum of 2 quarters · filed 2012-07-26
$8.39M
10-Q · filed 2011-10-28
$8.76M
derived: sum of 4 quarters · filed 2012-07-26
2011-06-30-$2.99M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26
$309.00K
10-Q · filed 2012-07-26
$678.00K
derived: sum of 3 quarters · filed 2012-07-26
$99.00K
derived: sum of 4 quarters · filed 2012-07-26
2011-03-31$3.30M
10-Q · filed 2012-04-26
$3.67M
derived: sum of 2 quarters · filed 2012-04-26
$3.09M
derived: sum of 3 quarters · filed 2012-04-26
$3.27M
derived: sum of 4 quarters · filed 2012-04-26
2010-12-31$369.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
-$210.00K
derived: sum of 2 quarters · filed 2012-02-28
-$30.00K
derived: sum of 3 quarters · filed 2012-02-28
-$2.11M
10-K · filed 2012-02-28
2010-09-30-$579.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28
-$399.00K
derived: sum of 2 quarters · filed 2011-10-28
-$2.48M
10-Q · filed 2011-10-28
2010-06-30$180.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28
-$1.90M
10-Q · filed 2011-07-28
2010-03-31-$2.08M
10-Q · filed 2011-04-29
2009-12-31$1.64M
10-K · filed 2012-02-28